Böbrek Hücreli Karsinomlu Hastaların Demografik Özellikleri ve Tedavi Sonuçları: Tek Merkez Deneyimi

by Arife Ulaş, Burak Bilgin, Didem Şener Dede, F. Tuğba Köş, Muhammed Bülent Akıncı, Mehmet Ali Nahit Şendur, Bülent Yalçın
Published 2016-05-01

Der Einfluss des Multityrosinkinaseinhibitors Sunitinib auf die Proliferation und Steroidbiosynthese von Nebennierenkarzinomzellen in vitro

by Reuter, Miriam
Published 2015

Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma

by Paula Aldaz, Jaione Auzmendi-Iriarte, Maika Durántez, Irene Lasheras-Otero, Estefania Carrasco-Garcia, M. Victoria Zelaya, Laura Bragado, Ana Olías-Arjona, Larraitz Egaña, Nicolás Samprón, Idoia Morilla, Marta Redondo-Muñoz, Mikel Rico, Massimo Squatrito, Marta Maria-Alonso, Joaquín Fernández-Irigoyen, Enrique Santamaria, Iñaki M. Larráyoz, Claudia Wellbrock, Ander Matheu, Imanol Arozarena
Published 2021-01-01

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

by Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello
Published 2019-08-01

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats

by Mohammad Nasser Hashemian, Hadi Z Mahrjerdi, Mehdi Mazloumi, Mona S Safizadeh, Yadollah Shakiba, Firouzeh Rahimi, Mohsen Afarideh, Mohamad Ali Zare, Mohammadreza Fallah Tafti, Bahram Bohrani Sepidan, Mohammad Ali Abtahi, Seyed-Hossein Abtahi
Published 2017-01-01

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies

by Xinan Sheng, Jie Jin, Zhisong He, Yiran Huang, Aiping Zhou, Jinwan Wang, Xiubao Ren, Dingwei Ye, Xu Zhang, Shukui Qin, Fangjian Zhou, Binhui Wang, Jun Guo
Published 2020-03-01

Acute Acalculous Cholecystitis Associated with Sunitinib Treatment for Renal Cell Carcinoma

by Se Woong Choi, Jeong Min Lee, Dong Gyun Kim, Myung Hwan Noh
Published 2020-02-01

Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

by Schem Christian, Bauerschlag Dirk, Bender Sascha, Lorenzen Ann-Christin, Loermann Daniel, Hamann Sigrid, Rösel Frank, Kalthoff Holger, Glüer Claus C, Jonat Walter, Tiwari Sanjay
Published 2013-01-01

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models

by Devalingam Mahalingam, Jennifer S. Carew, Claudia M. Espitia, Robbert H. Cool, Francis J. Giles, Steven de Jong, Steffan T. Nawrocki
Published 2019-06-01

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

by Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X
Published 2018-07-01

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate

by Joan Manel Gasent Blesa, Enrique Grande Pulido, Juan Laforga Canales, Vicente Alberola Candel
Published 2009-12-01

Gallbladder Metastasis from Renal Cell Carcinoma

by Takashi Kawahara, Hisashi Ohshiro, Zenkichi Sekiguchi, Mitsuko Furuya, Kazuhiro Namura, Hiroki Itoh, Futoshi Sano, Kaoru Kawaji, Narihiko Hayashi, Kazuhide Makiyama, Noboru Nakaigawa, Takehiko Ogawa, Hiroji Uemura, Masahiro Yao, Yoshinobu Kubota
Published 2010-01-01

Leukocytoclastic Vasculitis after Long-Term Treatment with Sunitinib: A Case Report

by Alexandra Karadimou, Magdalini Migou, Afroditi Economidi, Alexandros Stratigos, Christos Kittas, Meletios A. Dimopoulos, Aristotle Bamias
Published 2011-08-01

Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells

by Miaki Uzu, Hiromi Sato, Ryota Yamada, Tatsuro Kashiba, Yukihiro Shibata, Katsunori Yamaura, Koichi Ueno
Published 2015-05-01

Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy

by Changzhen Ren, Changzhen Ren, Kaiqiang Sun, Yanda Zhang, Yangxi Hu, Bowen Hu, Jian Zhao, Zhiqing He, Ru Ding, Weizhong Wang, Chun Liang
Published 2021-04-01

Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression

by Vincenzo Quagliariello, Massimiliano Berretta, Simona Buccolo, Martina Iovine, Andrea Paccone, Ernesta Cavalcanti, Rosaria Taibi, Monica Montopoli, Gerardo Botti, Nicola Maurea
Published 2021-06-01

Development and validation of a HPTLC method for analysis of Sunitinib malate

by Monireh Hajmalek, Masoumeh Goudarzi, Solmaz Ghaffari, Hossein Attar, Mehrnoosh Ghanbari Mazlaghan

Sunitinib and Imatinib Display Differential Cardiotoxicity in Adult Rat Cardiac Fibroblasts That Involves a Role for Calcium/Calmodulin Dependent Protein Kinase II

by Calum J. McMullen, Susan Chalmers, Rachel Wood, Margaret R. Cunningham, Susan Currie
Published 2021-02-01

Sunitinib-Induced Acute Liver Failure

by Anum Aqsa, Sami Droubi, Shivantha Amarnath, Hassan Al-Moussawi, Jeffrey Abergel
Published 2021-01-01

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma

by Chuanjie Zhang, Xuan Lu, Jingyi Huang, Hongchao He, Li Chen, Yihan Liu, Haofei Wang, Yang Xu, Siwei Xing, Xiaohao Ruan, Xiaoqun Yang, Lu Chen, Danfeng Xu
Published 2021-02-01